BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 3992622)

  • 1. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
    Zielinski JJ; Haidukewych D; Leheta BJ
    Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects of carbamazepine-phenytoin interaction.
    Zielinski JJ; Haidukewych D
    Ther Drug Monit; 1987; 9(1):21-3. PubMed ID: 3576659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
    Cloyd JC; Marino S; Birnbaum AK
    Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in carbamazepine plasma concentrations in psychiatric patients during treatment.
    Kanarkowski R; Rybakowski J; Lehmann W; Matkowski K
    Pol J Pharmacol Pharm; 1991; 43(6):479-85. PubMed ID: 1821043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study.
    Hayashi T; Higuchi H; Tomoyasu Y; Ishii-Maruhama M; Maeda S; Miyawaki T
    J Anesth; 2016 Feb; 30(1):166-9. PubMed ID: 26272251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy.
    Ojemann LM; Shastri RA; Wilensky AJ; Friel PN; Levy RH; McLean JR; Buchanan RA
    Ther Drug Monit; 1986; 8(3):293-6. PubMed ID: 3750373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
    Liu H; Delgado MR
    Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures.
    Van Der Meyden CH; Kruger AJ; Müller FO; Rabie W; Schall R
    Epilepsia; 1994; 35(1):189-94. PubMed ID: 8112244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
    Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.